These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 31118692)

  • 21. N6-methyladenosine methyltransferase KIAA1429 promoted ovarian cancer aerobic glycolysis and progression through enhancing ENO1 expression.
    Gan L; Zhao S; Gao Y; Qi Y; Su M; Wang A; Cai H
    Biol Direct; 2023 Oct; 18(1):64. PubMed ID: 37807062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. circ_KIAA1429 accelerates hepatocellular carcinoma advancement through the mechanism of m
    Wang M; Yang Y; Yang J; Yang J; Han S
    Life Sci; 2020 Sep; 257():118082. PubMed ID: 32653519
    [TBL] [Abstract][Full Text] [Related]  

  • 23. lncRNA POU6F2-AS1 Regulated by KIAA1429 Contributes to Colorectal Cancer Progression in an m
    Lu D; Chen A
    Mol Biotechnol; 2023 Dec; ():. PubMed ID: 38103097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification and Validation of the N6-Methyladenosine RNA Methylation Regulator YTHDF1 as a Novel Prognostic Marker and Potential Target for Hepatocellular Carcinoma.
    Bian S; Ni W; Zhu M; Song Q; Zhang J; Ni R; Zheng W
    Front Mol Biosci; 2020; 7():604766. PubMed ID: 33363211
    [No Abstract]   [Full Text] [Related]  

  • 25. KIAA1429 increases FOXM1 expression through YTHDF1-mediated m6A modification to promote aerobic glycolysis and tumorigenesis in multiple myeloma.
    Wu Y; Luo Y; Yao X; Shi X; Xu Z; Re J; Shi M; Li M; Liu J; He Y; Du X
    Cell Biol Toxicol; 2024 Jul; 40(1):58. PubMed ID: 39060874
    [TBL] [Abstract][Full Text] [Related]  

  • 26. METTL3 facilitates the progression of hepatocellular carcinoma by modulating the m6A level of USP7.
    Li Y; Cheng X; Chen Y; Zhou T; Li D; Zheng WV
    Am J Transl Res; 2021; 13(12):13423-13437. PubMed ID: 35035685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aberrations of m6A regulators are associated with tumorigenesis and metastasis in head and neck squamous cell carcinoma.
    Arumugam P; George R; Jayaseelan VP
    Arch Oral Biol; 2021 Feb; 122():105030. PubMed ID: 33383437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2.
    Chen M; Wei L; Law CT; Tsang FH; Shen J; Cheng CL; Tsang LH; Ho DW; Chiu DK; Lee JM; Wong CC; Ng IO; Wong CM
    Hepatology; 2018 Jun; 67(6):2254-2270. PubMed ID: 29171881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MiR-186-5p prevents hepatocellular carcinoma progression by targeting methyltransferase-like 3 that regulates m6A-mediated stabilization of follistatin-like 5.
    Ma S; Chen F; Lin C; Sun W; Wang D; Zhou S; Chang S; Lu Z; Zhang D
    Heliyon; 2024 Mar; 10(5):e26767. PubMed ID: 38463829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. METTL14 promotes the migration and invasion of breast cancer cells by modulating N6‑methyladenosine and hsa‑miR‑146a‑5p expression.
    Yi D; Wang R; Shi X; Xu L; Yilihamu Y; Sang J
    Oncol Rep; 2020 May; 43(5):1375-1386. PubMed ID: 32323801
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Promotive role of USP29-mediated deubiquitination in malignant proliferation of colorectal cancer cells via the KIAA1429/SOX8 axis.
    Li J; Yang J; Chen Z; Liu L; Wang H; Deng Q; Chen Y; Que Y; Fu Z
    Biomol Biomed; 2023 May; 23(3):483-495. PubMed ID: 36373629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role and mechanism of JAK2/STAT3 signaling pathway regulated by m6A methyltransferase KIAA1429 in osteosarcoma.
    Luo J; Wang X; Chen Z; Zhou H; Xiao Y
    J Bone Oncol; 2023 Apr; 39():100471. PubMed ID: 36915895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of KIAA1429/HK1 axis enhances the sensitivity of liver cancer cells to sorafenib by regulating the Warburg effect.
    Liu D; Shan M; Zeng R; He M; Dai X; Lu L; Yang M; He H; Zhang Y; Xiang L; Chen A; Sun L; He F; Lian J
    Biochem Pharmacol; 2024 Sep; 227():116419. PubMed ID: 38996929
    [TBL] [Abstract][Full Text] [Related]  

  • 34. KIAA1429 regulates lung adenocarcinoma proliferation and metastasis through the PI3K/AKT pathway by modulating ARHGAP30 expression.
    Guo W; Wang T; Huai Q; Guo L; Wang X; He J
    Thorac Cancer; 2024 Jun; 15(18):1397-1409. PubMed ID: 38717936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner.
    Yu D; Pan M; Li Y; Lu T; Wang Z; Liu C; Hu G
    J Exp Clin Cancer Res; 2022 Jan; 41(1):6. PubMed ID: 34980207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. m6A 'writer' KIAA1429 regulates the proliferation and migration of endothelial cells in atherosclerosis.
    Rong J; Jie Y; Zhao H
    Mol Biotechnol; 2023 Jul; 65(7):1198-1206. PubMed ID: 36463391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. KIAA1429 protects hepatocellular carcinoma cells from ferroptotic cell death with a m
    Wang H; Chen W; Cui Y; Gong H; Li H
    J Cell Mol Med; 2023 Dec; 27(24):4118-4132. PubMed ID: 37830241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. m6A-Induced LncRNA MEG3 Suppresses the Proliferation, Migration and Invasion of Hepatocellular Carcinoma Cell Through miR-544b/BTG2 Signaling.
    Wu J; Pang R; Li M; Chen B; Huang J; Zhu Y
    Onco Targets Ther; 2021; 14():3745-3755. PubMed ID: 34163177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene Signatures and Prognostic Values of m6A Regulators in Hepatocellular Carcinoma.
    Wang P; Wang X; Zheng L; Zhuang C
    Front Genet; 2020; 11():540186. PubMed ID: 33133142
    [TBL] [Abstract][Full Text] [Related]  

  • 40. METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer.
    Chen X; Xu M; Xu X; Zeng K; Liu X; Pan B; Li C; Sun L; Qin J; Xu T; He B; Pan Y; Sun H; Wang S
    Mol Cancer; 2020 Jun; 19(1):106. PubMed ID: 32552762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.